Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2017

Open Access 01-12-2017 | Study protocol

Efficacy differences of electroacupuncture with single acupoint or matching acupoints for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trial

Authors: Bo Chen, Yang Guo, Xue Zhao, Li-li Gao, Bo Li, Tian-yi Zhao, Qi-wen Zhang, Jin-xing Zou, Ming-yue Li, Yong-ming Guo, Yi Guo, Xing-fan Pan

Published in: Trials | Issue 1/2017

Login to get access

Abstract

Background

Previous studies have shown that acupuncture is beneficial for the alleviation of chemotherapy-induced nausea and vomiting. However, there is a lack of clinical evidence concerning the effects of acupoint-matching on chemotherapy-induced nausea and vomiting.

Methods/design

This is a parallel randomized controlled trial to evaluate the occurrence of nausea and vomiting after chemotherapy (the incidence of nausea and vomiting, frequency, VAS score, RINVR rating) as the main outcome for cancer. Quality of life, anxiety and depression scores are the secondary outcomes. Quality of life, anxiety and depression scores are the secondary phase. Use of remedy drugs, routine blood examination, and blood biochemical tests are the safety evaluation. We also compare the different effects of ST36 (single acupoint), CV12 (single acupoint), and ST36-CV12 matching groups.

Discussion

The results of this trial are expected to explore the effects of matching different acupoints and to offer biologic plausibility for the use of acupuncture in the treatment of chemotherapy-induced nausea and vomiting (CINV).

Trial registration

This trial is registered with clinicaltrials.gov NCT02195921, The date of registration was 17 July 2014.
Appendix
Available only for authorised users
Literature
1.
Hesketh PJ, Grunberg SM, Gralla RJ, et al. The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin—the Aprepitant Protocol 052 Study Group. J Clin Oncol. 2003;21:4112–9.CrossRefPubMed
2.
Mancini I, Bruera E. Constipation in advanced cancer patients[J]. Support Care Cancer. 1998;6:356–64.CrossRefPubMed
3.
Lu W. Acupuncture for side effects of chemoradiation therapy in cancer patients Seminars in oncology nursing. WB Saunders. 2005;21:190–5.
4.
Ezzo J, Streitberger K, Schneider A. Cochrane systematic reviews examine P6 acupuncture-point stimulation for nausea and vomiting. J Altern Complement Med. 2006;12:489–95.CrossRefPubMed
5.
Lee MS, Kim KH, Choi SM, et al. Acupuncture for treating hot flashes in breast cancer patients: a systematic review. Breast Cancer Res Treat. 2009;115:497–503.CrossRefPubMed
6.
Posadzki P, Moon TW, Choi TY, et al. Acupuncture for cancer-related fatigue: a systematic review of randomized clinical trials. Support Care Cancer. 2013;21:2067–73.CrossRefPubMed
7.
Morey SS. NIH issues consensus statement on acupuncture. Am Fam Physician. 1998;57:2545–6.PubMed
8.
Naeim A, Dy SM, Lorenz KA, et al. Evidence-based recommendations for cancer nausea and vomiting. J Clin Oncol. 2008;26:3903–10.CrossRefPubMed
9.
Pomeranz B, Berman B. Scientific basis of acupuncture. Berlin Heidelberg: Springer; 2003.CrossRef
10.
Hu S, Du MH, Luo HM, et al. Electroacupuncture at Zusanli (ST36) prevents intestinal barrier and remote organ dysfunction following gut ischemia through activating the cholinergic anti-inflammatory-dependent mechanism. Evid Based Complement Alternat Med. 2013;2013:592127.PubMedPubMedCentral
11.
Dong LL, Liu AG, Wang JY, et al. Effect of acupuncture of Ho (ST 36)-plus Mu (CV 12)-acupoints on hypothalamic gonadotropin-releasing hormone mRNA and SP mRNA expression in stress-induced gastric ulcer rats. Acupunct Res. 2013;38:291–6.
12.
Basch E, Prestrud AA, Hesketh PJ, et al. Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2011;29:4189–98.CrossRefPubMedPubMedCentral
13.
World Health Organization. WHO standard acupuncture point locations in the Western Pacific Region. Geneva: World Health Organization; 2008. p. 181.
14.
Shen J, Wenger N, Glaspy J, et al. Electroacupuncture for control of myeloablative chemotherapy–Induced emesis: a randomized controlled trial. JAMA. 2000;284:2755–61.CrossRefPubMed
15.
Fu MR, Rhodes V, Xu B. The Chinese translation of the Index of Nausea, Vomiting, and Retching. Cancer Nurs. 2002;25(2):134–40.CrossRefPubMed
16.
Jantunen IT, Kataja VV, Muhonen TT. An overview of randomised studies comparing 5-HT 3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting. Eur J Cancer. 1997;33:66–74.CrossRefPubMed
17.
Janelsins MC, Tejani MA, Kamen C, et al. Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients. Expert Opin Pharmacother. 2013;14:757.CrossRefPubMedPubMedCentral
18.
Sanger GJ, Andrews PLR. Treatment of nausea and vomiting: gaps in our knowledge. Auton Neurosci. 2006;129:3–16.CrossRefPubMed
19.
Ariumi H, Saito R, Nago S, et al. The role of tachykinin NK-1 receptors in the area postrema of ferrets in emesis. Neurosci Lett. 2000;286:123–6.CrossRefPubMed
20.
Murakawa M, Adachi T, Nakao S, et al. Activation of the cortical and medullary dopaminergic systems by nitrous oxide in rats: a possible neurochemical basis for psychotropic effects and postanesthetic nausea and vomiting. Anesth Analg. 1994;78:376–81.CrossRefPubMed
Metadata
Title
Efficacy differences of electroacupuncture with single acupoint or matching acupoints for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trial
Authors
Bo Chen
Yang Guo
Xue Zhao
Li-li Gao
Bo Li
Tian-yi Zhao
Qi-wen Zhang
Jin-xing Zou
Ming-yue Li
Yong-ming Guo
Yi Guo
Xing-fan Pan
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Trials / Issue 1/2017
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-017-2186-y

Other articles of this Issue 1/2017

Trials 1/2017 Go to the issue

Research

The association of funding source on effect size in randomized controlled trials: 2013–2015 – a cross-sectional survey and meta-analysis

Study protocol

PORTAF – postoperative radiotherapy of non-small cell lung cancer: accelerated versus conventional fractionation – study protocol for a randomized controlled trial

Study protocol

MYPLAN –mobile phone application to manage crisis of persons at risk of suicide: study protocol for a randomized controlled trial

Study protocol

Extracorporeal shockwave therapy for the treatment of lower limb intermittent claudication: study protocol for a randomised controlled trial (the SHOCKWAVE 1 trial)

Erratum

Erratum to: Comparison of a drug-eluting balloon first and then bare metal stent with a drug-eluting stent for treatment of de novo lesions: study protocol of a randomized controlled trial

Study protocol

Metformin to Augment Strength Training Effective Response in Seniors (MASTERS): study protocol for a randomized controlled trial